TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

55.10$ +1.4% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Cash Flow

AnaptysBio Inc (ANAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ANAB
Line item Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
-25 -36 -34 -37 -21 -10 -67 -11 -40 -27 98 -26 4.5
0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 2.4
8.4 7.8 8.1 10 7.5 8.2 8.2 9.2 9.2 9.2 8.5 14 41
8.4 9.2
3.2 -9.0 -2.7 -7.4 8.7 -1.3 -69 2.5 -29 -74 20 -7.7 -91
0.2 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1
-20 31 49 69 -2.4 59 -29 15 36 103 74 35 248
2.2
-12 0.0 0.0 0.0 0.0 0.0 -0.5 -4.4 -51 -9.7 -3.4 0.0 -64
-13 -3.1 -5.2 -14 42 71 28 -29 -50 -10 -43 1.2 -103
-59 -8.9 9.7 18 18 120 -69 -24 -54 66 128 10 150
-26 -37 -35 -37 -21 -10 -67 -11 -40 -27 98 -26 4.4

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?